New Covid Shots Recommended for Americans 6 Months and Older This Fall [The New York Times]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: The New York Times
All Americans ages 6 months and older should receive one of the new Covid-19 vaccines when they become available this fall, scientific advisers to the Centers for Disease Control and Prevention said on Thursday.The recommendation comes as the nation faces a summer wave of Covid, with the number ofinfections risingMost Americans have acquired layers of immunity against the coronavirus from repeat infections or vaccine doses, or both. The vaccines now offer an incremental boost, remaining effective for only a few months as immunity wanes and the virus continues to evolve.Still, across every age group, a vast majority of Americans who were hospitalized for Covid did not receive one of the shots offered last fall, according to data presented at a meeting of the C.D.C.’s Advisory Committee on Immunization Practices.“Professionals and the public in general do not understand how much this virus has mutated,” said Carol Hayes, the committee’s liaison to the American College of Nurse-Midwives.
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- Novavax (NVAX) Falls More Steeply Than Broader Market: What Investors Need to Know [Yahoo! Finance]Yahoo! Finance
- Novavax (NVAX) Seeks Nod for Updated COVID-19 Jab in Europe [Yahoo! Finance]Yahoo! Finance
- Novavax seeks EMA approval for updated JN.1 Covid-19 vaccine [Yahoo! Finance]Yahoo! Finance
- Novavax Submits Application to European Medicines Agency for Updated Protein-based 2024-2025 Formula COVID-19 VaccinePR Newswire
- Novavax (NVAX) Ascends While Market Falls: Some Facts to Note [Yahoo! Finance]Yahoo! Finance
NVAX
Earnings
- 2/28/24 - Miss
NVAX
Analyst Actions
- 5/13/24 - HC Wainwright
NVAX
Sec Filings
- 6/25/24 - Form 4
- 6/21/24 - Form 4
- 6/20/24 - Form 4
- NVAX's page on the SEC website